About Sensemodi
Sensemodi is a company based in Lausanne (Switzerland) founded in 2009 by David Atienza, Jerome Thevenot, and Tomas Teijeiro. Sensemodi has raised $164.21 thousand across 1 funding round. Sensemodi offers products and services including VersaSens Platform, Smart Brace, and Cough Detection Device. Sensemodi operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
- Headquarter Lausanne, Switzerland
- Founders David Atienza, Jerome Thevenot, Tomas Teijeiro
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$164.21 K (USD)
in 1 rounds
-
Latest Funding Round
$164.21 K (USD), Seed
Jan 25, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sensemodi
Sensemodi offers a comprehensive portfolio of products and services, including VersaSens Platform, Smart Brace, and Cough Detection Device.
Enables development of wearable devices with sensors for real-time health data processing.
Assesses knee health and supports rehabilitation through non-contact sensors.
Tracks cough frequency and severity for personalized patient care and treatment.
Funding Insights of Sensemodi
Sensemodi has successfully raised a total of $164.21K through 1 strategic funding round. The most recent funding activity was a Seed round of $164.21 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Sensemodi
Investment portfolio details for Sensemodi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sensemodi
Detailed financials for Sensemodi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sensemodi Comparisons
Peer comparison for Sensemodi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sensemodi
Sensemodi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Contactless patient monitoring is provided for mental health facilities.
|
|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
Detailed competitors of Sensemodi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sensemodi
Complete news archive for Sensemodi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sensemodi
Sensemodi was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Sensemodi is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Sensemodi is a funded company, having raised a total of $164.21K across 1 funding round to date.
Sensemodi was founded in 2009 in Lausanne, Switzerland, within the health technology sector. A wearable device has been developed to assess knee joint health through acoustic, thermal, and kinematic sensors. Health scores are calculated from collected data, and a tool is provided for healthcare practitioners to review information and develop personalized care plans. Operations focus on data-driven joint monitoring for users and professionals.
Sensemodi's top competitors include Endotronix, TestCard and Oxehealth.
Sensemodi offers VersaSens Platform, Smart Brace, and Cough Detection Device.